The estimated Net Worth of Daron Evans is at least $553 Tausend dollars as of 12 March 2020. Mr Evans owns over 2,500 units of Nephros Inc stock worth over $252,995 and over the last 5 years he sold NEPH stock worth over $0. In addition, he makes $300,177 as Chief Exec. Officer of Specialty Renal Products und Inc at Nephros Inc.
Sign up
Mr Evans NEPH stock SEC Form 4 insiders trading
Mr has made over 5 trades of the Nephros Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 2,500 units of NEPH stock worth $16,625 on 12 March 2020.
The largest trade he's ever made was buying 43,172 units of Nephros Inc stock on 14 June 2019 worth over $25,903. On average, Mr trades about 5,686 units every 30 days since 2019. As of 12 March 2020 he still owns at least 134,215 units of Nephros Inc stock.
You can see the complete history of Mr Evans stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Daron G. Evans biography
Daron G. Evans is the Chief Exec. Officer of Specialty Renal Products, Inc at Nephros Inc.
What is the salary of Mr Evans?
As the Chief Exec. Officer of Specialty Renal Products und Inc of Nephros Inc, the total compensation of Mr Evans at Nephros Inc is $300,177. There are 1 executives at Nephros Inc getting paid more, with Andrew Astor having the highest compensation of $309,006.
How old is Mr Evans?
Mr Evans is 47, he's been the Chief Exec. Officer of Specialty Renal Products und Inc of Nephros Inc since . There are 5 older and 1 younger executives at Nephros Inc. The oldest executive at Nephros Inc is Andrew Astor, 64, who is the CEO, CFO, Pres & Director.
What's Mr Evans's mailing address?
Daron's mailing address filed with the SEC is C/O NEPHROS, INC., 380 LACKAWANNA PLACE, SOUTH ORANGE, NJ, 07079.
Insiders trading at Nephros Inc
Over the last 6 years, insiders at Nephros Inc have traded over $0 worth of Nephros Inc stock and bought 188,822 units worth $443,998 . The most active insiders traders include Capital Lp Wexford Gp Llcda..., Robert R. Jr. Banks und Andrew Astor. On average, Nephros Inc executives and independent directors trade stock every 70 days with the average trade being worth of $15,834. The most recent stock trade was executed by Arthur H Amron on 28 May 2024, trading 5,000 units of NEPH stock currently worth $11,200.
What does Nephros Inc do?
nephros is a commercial stage medical device company that develops and sells high performance liquid purification filters. nephros filters capture contaminants as small as 5 nanometers in size; they minimize exposure to a wide variety of bacteria, viruses, fungi, parasites, and endotoxins. nephros filters use a proprietary hollow fiber technology; the hollow fiber design enables the filters to optimize the three elements critical to filter performance: • filtration – as low as 5 nanometers • flow rate – minimal disruption • filter life – up to 12 months nephros was founded in 1997, by healthcare professionals affiliated with columbia university medical center, initially to address the needs of chronic renal failure patients. the company has developed an alternative to current hemodialysis therapy known as mid-dilution hemodiafiltration (mid-hdf). nephros’ proprietary blood purification technologies enable mid-hdf to be offered to chronic renal failure patients. nephros mid-dilution fil
What does Nephros Inc's logo look like?
Complete history of Mr Evans stock trades at Nephros Inc
Nephros Inc executives and stock owners
Nephros Inc executives and other stock owners filed with the SEC include:
-
Andrew Astor,
CEO, CFO, Pres & Director -
Daron G. Evans,
Chief Exec. Officer of Specialty Renal Products, Inc -
Daniel D'Agostino,
Chief Financial Officer -
Arthur Amron,
Independent Director -
Oliver Spandow,
Director -
Malcom Persen,
Director -
Alisa Lask,
Director -
Thomas Gwydir,
Director -
Andrew Astor,
President, Chief Executive Officer, Director -
Daron Evans,
Chief Executive Officer of Specialty Renal Products -
Greg Lucas,
Pres of Aether Water Systems -
Wesley S. Lobo,
Chief Commercial Officer -
Shane Sullivan,
VP of Sales -
Joleen C. Turner,
VP of Marketing & Bus. Devel. -
Paul A Mieyal,
Director -
Joseph Michael Harris,
Director -
Robert R. Jr. Banks,
President and CEO -
Tom Gwydir,
Director -
Malcolm C Persen,
Director -
Capital Lp Wexford Gp Llcda...,
-
Wesley S. Lobo,
Chief Marketing Officer -
Judy Krandel,
Chief Financial Officer